Literature DB >> 9414070

Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review.

I Mujika1, S Padilla.   

Abstract

Creatine supplementation has become a common practice among competition athletes participating in different sports over the last few years. The mechanism by which supplementary creatine could have potential ergogenic effects would be an increased muscle creatine and phosphocreatine concentration, leading to a higher rate of ATP resynthesis, a delay in the onset of muscular fatigue and a facilitated recovery during repeated bouts of high-intensity exercise. A critical review of the literature reveals that these ergogenic effects, when found, have been generally shown in untrained subjects performing several exercise bouts under laboratory conditions. The limited body of scientific data available concerning highly trained athletes performing single competition-like exercise tasks indicates that this type of population does not benefit from creatine supplementation. Therefore, the widespread use of creatine ingestion to improve competition performance does not seem to be justified. The potential interest of creatine supplementation for elite athletes could be related to an increased ability to perform repeated high-intensity exercise bouts, either during training or during competition in sports in which repeated efforts are required (e.g. soccer, basketball), but this possibility needs scientific confirmation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414070     DOI: 10.1055/s-2007-972670

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  15 in total

Review 1.  Adverse effects of creatine supplementation: fact or fiction?

Authors:  J R Poortmans; M Francaux
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 2.  Creatine supplementation and exercise performance: a brief review.

Authors:  Stephen P Bird
Journal:  J Sports Sci Med       Date:  2003-12-01       Impact factor: 2.988

3.  Creatine-induced activation of antioxidative defence in myotube cultures revealed by explorative NMR-based metabonomics and proteomics.

Authors:  Jette F Young; Lotte B Larsen; Anders Malmendal; Niels Chr Nielsen; Ida K Straadt; Niels Oksbjerg; Hanne C Bertram
Journal:  J Int Soc Sports Nutr       Date:  2010-02-04       Impact factor: 5.150

4.  Creatine supplementation and performance in 6 consecutive 60 meter sprints.

Authors:  C Javierre; J R Barbany; V M Bonjorn; M A Lizárraga; J L Ventura; R Segura
Journal:  J Physiol Biochem       Date:  2004-12       Impact factor: 4.158

Review 5.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 6.  Effects of creatine supplementation on performance and training adaptations.

Authors:  Richard B Kreider
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

7.  Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.

Authors:  Patrick R Stevens; Jeremy W Gawryluk; Liang Hui; Xuesong Chen; Jonathan D Geiger
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

Review 8.  Creatine supplementation and swim performance: a brief review.

Authors:  Melissa J Hopwood; Kenneth Graham; Kieron B Rooney
Journal:  J Sports Sci Med       Date:  2006-03-01       Impact factor: 2.988

9.  Contribution of creatine to protein homeostasis in athletes after endurance and sprint running.

Authors:  Fu-Chun Tang; Chun-Chen Chan; Po-Ling Kuo
Journal:  Eur J Nutr       Date:  2013-02-08       Impact factor: 5.614

10.  Effects of a multi-nutrient supplement on exercise performance and hormonal responses to resistance exercise.

Authors:  William J Kraemer; Disa L Hatfield; Barry A Spiering; Jakob L Vingren; Maren S Fragala; Jen-Yu Ho; Jeff S Volek; Jeffrey M Anderson; Carl M Maresh
Journal:  Eur J Appl Physiol       Date:  2007-08-16       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.